Retinal Neovascularization
Information
- Disease name
- Retinal Neovascularization
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02876198 | Completed | Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF | July 1, 2016 | April 15, 2021 | |
| NCT00564148 | Completed | Phase 2 | Intravitreal Avastin in Proliferative Retinopathies | July 2007 | December 2009 |
| NCT01024998 | Completed | Phase 1 | Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) | January 11, 2010 | July 2018 |
| NCT01102946 | Completed | Phase 2 | Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy | February 2009 | February 2011 |
| NCT01494805 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration | December 2011 | August 2017 |
| NCT01769183 | Completed | Phase 2 | Squalamine for the Treatment in Proliferative Diabetic Retinopathy | February 2013 | August 2014 |
| NCT00000153 | Completed | Phase 3 | Krypton-Argon Regression of Neovascularization Study (KARNS) | December 1984 | |
| NCT04650672 | Completed | Daily Testing at Home by NV-AMD Subjects With Notal Home OCT. | December 8, 2020 | September 30, 2021 | |
| NCT05650047 | Recruiting | Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD | September 9, 2022 | September 9, 2023 | |
| NCT03211741 | Recruiting | Phase 4 | Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema | November 22, 2013 | December 31, 2024 |
| NCT05130385 | Recruiting | High Resolution Optical Coherence Tomography | November 30, 2021 | November 30, 2023 | |
| NCT02088151 | Terminated | N/A | Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina | June 2010 | February 1, 2022 |
| NCT02486484 | Unknown status | Phase 2 | Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection | March 2015 | December 2019 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030666
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015861